Biopharma perspectives 2021-24 with Trump or Biden

Biopharma perspectives 2021-24 with Trump or Biden

Business Development
By Juan Rivera-Mata, Markentry USA Partner The US elections may entail different scenarios for the biopharmaceutical industry. During his term, Trump has tried to eliminate “Obamacare” (a law that, among other things, makes it mandatory for companies to provide health insurance to their employees), and Biden has used that possibility as a main element of his campaign. But, at the same time as the President, local and state officials are also elected, and the House of Representatives and 1/3 of the Senate are renewed. It appears that Democrats will remain a majority in the House, but the Senate, now Republican, may go "blue." Trump has appointed 3 members of the Supreme Court - for life -, making it (6/3) conservative. The obligation to have health insurance (and any subsequent reform) will…
Read More
Exporting remote services to the US: opportunities and challenges during COVID-19 times

Exporting remote services to the US: opportunities and challenges during COVID-19 times

Blog
By Gonzalo Garcia, Founder and CEO of Markentry USA CONTENTS Introduction Exporting services to the US: general considerations Opportunities created by COVID-19 Barriers to entry Entry strategies for companies Entry strategies for freelancers Added value derived from the sale of services in the US Conclusions 1. Introduction In 2019, the US imported a total of $588 billion in services (ref US Census). An important part of them can be provided remotely using information and communication technologies, such as financial services, insurance, research and development, consulting, engineering, training, design and sale of intellectual property. The USA is the largest importer of services in the world (10% of the global total, (ref CRS) and one of the most open developed economies New technologies, the high degree of openness of the American culture…
Read More
COVID-19: Why enter the US market now?

COVID-19: Why enter the US market now?

Business
By Gonzalo Garcia, Founder and CEO of Markentry USA Distribution of confirmed COVID-19 cases in the US (Johns Hopkins University) CONTENTS Introduction: Why now?State of the US economy, the most powerful and resilientGeographical and sectoral differences: the US, a different and diverse worldImpact on US international trade: open for businessStatus and forecast of travel restrictions: changes coming up soonImmigration restrictions: obstacle and opportunityBusiness opportunities: plentiful if you look carefullyConclusions 1. Introduction: Why now? The famous US scientist Carl Sagan once said:  Extinction is the rule. Survival is the exceptionThis idea, related to the species that populate the Earth, can be extrapolated to the business world. Under normal conditions, in developed economies more than two thirds of companies disappear before reaching the age of 10. Half of SMEs do not reach 5 years.…
Read More